CalonLab

📢 Published in @Gut_BMJ! We define CTHRC1-CAFs as a #biomarker of clinical outcome and response to #immunotherapy in MSS and MSI #colorectal #cancer. gut.bmj.com/content/early/… @mariglesiascoma @Calon_Alex @BatlleLab @ClaraMontagut @hospitaldelmar @HMar_research @IRBBarcelona

📢 Our paper is out! We define CTHRC1-CAFs as #biomarker of response to #immunotherapy in MSS and MSI #CRC Great teamwork @CalonLab @BatlleLab @mariglesiascoma Thanks @ContraCancerEs for their support 🔗 gut.bmj.com/content/early/…

🔬CTHRC1 identificat com biomarcador clau en càncer colorectal 🧬Liderat per @Calon_Alex @HMar_research i @BatlleLab @IRBBarcelona 📊Validat en ~3.000 pacients 🧪Amb @ClaraMontagut i @mariglesiascoma 👉Estudi: researchmar.net/noticies/view.… @hmarpath @CIBER_ISCIII

💡Chemists, physicists, biologists, clinicians, and computational scientists — 4 teams, one vision: bringing new hope to people facing colorectal cancer. Thanks to @FundlaCaixa / Health Research Call 2025. @CanalUGR @uniovi_info @cnag_eu @CaixaResearch @HMar_research

1/ 🧬 Colorectal cancer is still one of the most frequent and deadly and many patients don't respond well to chemotherapy. With the support of #HealthResearch, @CalonLab will investigate cells in the tumour environment to improve and personalise treatments. 👇 tinyurl.com/ymj9aw3v

🔬 Join us at the @hmar_research-@UPFbiomed Seminar! 🗓️16/9 📌Ramon y Cajal Room Talks by @JLinaresA @hospitaldelmar - @HMar_research & @TheAnaJanic @UPFbiomed 👉researchmar.net/agenda/969/ @the_prbb

La @JaneMateu_FDT beca un projecte liderat per la Dra. Sònia Segura Mirarà de determinar el valor pronòstic de les molècules del microambient tumoral en #melanoma #Dermatologia #PremiosJMF2025 #BecasJMF @HMar_research @CalonLab @Calon_Alex hospitaldelmar.cat/ca/noticies/vi…

Muchísimas gracias a @criscancer por la oportunidad de poder disfrutar del Programa CRIS Médico Traslacional 👩🏻‍⚕️ Esta ayuda será un gran impulso para seguir investigando y trabajando para mejorar la supervivencia del #mCRC Gracias @ClaraMontagut y @HMar_research por su apoyo

CRIS contra el #càncer premia la Dra. Jenniffer Linares La investigadora de l'Institut de Recerca de l'Hospital del Mar ha estat guardonada amb el Programa CRIS de Talento Médico Traslacional #TalentMAR #recerca #oncologia #DíaCienciaCRIS25 @JLinaresA researchmar.net/noticies/1340/…

Three researchers from the @HMar_research receive #research grants from @ContraCancerBCN Lluís Espinosa, @JLinaresA and @ClaraMontagut lead the selected projects. @SoniaServitja participates in a study led by @IRBBarcelona #CancerResearch #TalentMAR imim.es/news/705/three…

El Dr. @Calon_Alex explica la #recerca que ha permès crear #MIRO, dispositiu que replica els #tumors per estudiar l’eficàcia de la #immunoteràpia Treball amb @IBECBarcelona i @CIPFciencia que publica @NatureComms #oncologia #càncer #recerca youtu.be/WyVfouw-Fjc?fe…

A team led by @HMar_research, @IBECBarcelona, @CIPFciencia, has developed #MIRO, a device that allows to replicate the characteristics of #tumours and their environment using patient cells #oncologia #càncer #recerca #immunoteràpia hospitaldelmar.cat/en/noticies/vi…

Paper alert! 📢 With the @XavierTrepat lab, we have developed MIRO, an #invitro platform to recreate #Cancer cells interactions with their microenvironment to test new #Immunotherapy strategies. nature.com/articles/s4146… @HMar_research @hospitaldelmar @IBECBarcelona @NatureComms

El Dr. @Calon_Alex ha estat un dels investigadors que han participat en la jornada 'Evolution of Cancer Pharmacology', organitzada per la @SIFfarmacologia, presentant els detalls de la #recerca que porta a terme el @CalonLab #TalentMAR #oncologia

It was a pleasure to participate!

Very proud of Dr. @JLinaresA, oncologist in our lab, for winning the Young Talent Award from @ufvmadrid and @merck_es!! @hospitaldelmar @HMar_research @the_prbb

The prognostic potential of CDX2 in colorectal cancer: harmonizing biology and clinical practice - Cancer Treatment Reviews cancertreatmentreviews.com/article/S0305-…

💥Just OUT: the role of CDX2 loss in CRC 🧫. 🤝A collaborative effort with @CalonLab 📌 Is the current classification of CDX2 loss appropriate? 📌 Will be possible to reverse CDX2 loss and improve patients’ prognosis? Work supported by @fundacionmutua cancertreatmentreviews.com/article/S0305-…

❗️📢 Just out! Review on the roles of CDX2 in #colorectal #cancer, where we discuss the biology and clinical relevance of CDX2 as an actionable #biomarker of #CRC. @TarazonaNoelia @Calon_Alex @AndresC27622123 @hospitaldelmar @HMar_research @incliva_iis cancertreatmentreviews.com/article/S0305-…

We are #hiring!! Fully funded #postdoc position in our lab! @Calon_Alex Please share! For more info: imim.cat/media/upload//… #Cancer #immunotherapy #chemotherapy #TalentMAR @hospitaldelmar @ContraCancerEs @UPFbiomed @the_prbb @ccr_mar